Guardant Health’s Shield Blood Test Shows Promise in Detecting Colorectal Cancer
Guardant Health, Inc. announces results from the ECLIPSE study showing the effectiveness of its Shield™ blood test for detecting colorectal cancer in average-risk adults. The study demonstrated the test’s high sensitivity in detecting individuals with CRC and pathology-confirmed Stages I–III, with potential to detect more CRCs at a curable stage than traditional screening methods.
Simple Blood Tests Could Revolutionize Alzheimer’s Diagnosis
The possibility of simple blood tests to help diagnose Alzheimer’s disease faster has been given a boost after researchers revealed evidence that they can rival costly brain scans or painful lumbar punctures for accuracy. Recent studies have brought the possibility…
Rice University Scientists Develop Noninvasive Method to Monitor Gene Expression in the Brain
This week, Rice University scientists have made a groundbreaking development in the study of gene expression in the brain. Their research, published in Nature Biotechnology, introduces a noninvasive method to monitor gene expression dynamics in the brain through a simple…